C12Y 304/16001
Serine carboxypeptidase
Official title: Serine carboxypeptidase (3.4.16.1) (C12Y304/16005, C12Y304/16006 take precedence)
C12Y304/16001 (Serine carboxypeptidase) appears on 0 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 5
- Assignees
- 2
- Inventors
- 8
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Methods and compositions for the treatment of amyloidosis27 Apr 2023US 2023/0127775 A1Ultragenyx Pharmaceutical Inc.
- Methods and compositions for the treatment of amyloidosis29 Jul 2021US 2021/0228694 A1Ultragenyx Pharmaceutical Inc.
- Methods and compositions for the treatment of amyloidosis20 Jun 2019US 2019/0183985 A1Ultragenyx Pharmaceutical Inc.
- Rheumatoid arthritis related biomarker7 Dec 2017US 2017/0350884 A1The Catholic University of Korea Industry-Academic Cooperation Foundation
- Methods and compositions for the treatment of amyloidosis4 May 2017US 2017/0119861 A1Ultragenyx Pharmaceutical Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.